Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report

Abstract Background Maintenance therapy using poly(adenosine diphosphate-ribose)polymerase inhibitors may have adverse events, including hematological toxicity, and may limit therapeutic potential in patients with cancer. Niraparib-induced anemia negatively impacts one’s quality of life. Its amelior...

Full description

Bibliographic Details
Main Authors: Hiroshi Kobayashi, Yuki Yamada
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-022-03666-3